C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors
Nobuyuki Matsunaga(Takeda (Japan)), Akihiro Tasaka(Takeda (Japan)), Tomohiro Kaku(Takeda (Japan)), Masami Kusaka(Takeda (Japan)), T. AONO(Takeda (Japan)), Takahito Hara(Takeda (Japan)), Hiroshi Miki(Takeda (Japan)), Fumio Itoh(Takeda (Japan)), Toshimasa Tanaka(Takeda (Japan)), Masuo Yamaoka, M. Iwasaki(RIKEN)
Cited by 40
Related Papers
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
|Proceedings of the National Academy of Sciences|1989|638
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent
|Biochemical and Biophysical Research Communications|1991|323
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
|British Journal of Cancer|1994|243